Annual FCF:
-$399.80M+$15.95M(+3.84%)Summary
- As of today, CYTK annual free cash flow is -$399.80 million, with the most recent change of +$15.95 million (+3.84%) on December 31, 2024.
- During the last 3 years, CYTK annual free cash flow has fallen by -$208.40 million (-108.89%).
- CYTK annual free cash flow is now -1229.81% below its all-time high of $35.39 million, reached on December 31, 2016.
Performance
CYTK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$132.38M+$4.90M(+3.57%)Summary
- As of today, CYTK quarterly free cash flow is -$132.38 million, with the most recent change of +$4.90 million (+3.57%) on June 30, 2025.
- Over the past year, CYTK quarterly free cash flow has dropped by -$31.15 million (-30.78%).
- CYTK quarterly free cash flow is now -271.98% below its all-time high of $76.97 million, reached on December 31, 2016.
Performance
CYTK Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$438.72M-$31.15M(-7.64%)Summary
- As of today, CYTK TTM free cash flow is -$438.72 million, with the most recent change of -$31.15 million (-7.64%) on June 30, 2025.
- Over the past year, CYTK TTM free cash flow has dropped by -$37.45 million (-9.33%).
- CYTK TTM free cash flow is now -1339.82% below its all-time high of $35.39 million, reached on December 31, 2016.
Performance
CYTK TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CYTK Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +3.8% | -30.8% | -9.3% |
| 3Y3 Years | -108.9% | -44.9% | -84.0% |
| 5Y5 Years | -327.5% | -367.7% | -544.6% |
CYTK Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -108.9% | +3.8% | -98.0% | +3.6% | -61.3% | +1.0% |
| 5Y | 5-Year | >-9999.0% | +3.8% | -390.3% | +3.6% | >-9999.0% | +1.0% |
| All-Time | All-Time | -1229.8% | +3.8% | -272.0% | +3.6% | -1339.8% | +1.0% |
CYTK Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$132.38M(+3.6%) | -$438.72M(-7.6%) |
| Mar 2025 | - | -$137.28M(-105.3%) | -$407.57M(-1.9%) |
| Dec 2024 | -$399.80M(+3.8%) | -$66.86M(+34.6%) | -$399.80M(+1.8%) |
| Sep 2024 | - | -$102.20M(-1.0%) | -$407.05M(-1.4%) |
| Jun 2024 | - | -$101.23M(+21.8%) | -$401.27M(+5.0%) |
| Mar 2024 | - | -$129.51M(-74.7%) | -$422.57M(-1.6%) |
| Dec 2023 | -$415.75M(-33.7%) | -$74.11M(+23.1%) | -$415.75M(+6.2%) |
| Sep 2023 | - | -$96.42M(+21.3%) | -$443.03M(-1.9%) |
| Jun 2023 | - | -$122.52M(+0.1%) | -$434.57M(-7.7%) |
| Mar 2023 | - | -$122.69M(-21.0%) | -$403.38M(-29.8%) |
| Dec 2022 | -$310.85M(-62.4%) | -$101.39M(-15.3%) | -$310.85M(-14.3%) |
| Sep 2022 | - | -$87.96M(+3.7%) | -$271.95M(-14.0%) |
| Jun 2022 | - | -$91.33M(-202.8%) | -$238.46M(-28.6%) |
| Mar 2022 | - | -$30.16M(+51.7%) | -$185.41M(+3.1%) |
| Dec 2021 | -$191.39M(-8975.1%) | -$62.49M(-14.7%) | -$191.39M(-129.7%) |
| Sep 2021 | - | -$54.47M(-42.3%) | -$83.31M(-388.2%) |
| Jun 2021 | - | -$38.29M(-5.9%) | -$17.06M(-141.1%) |
| Mar 2021 | - | -$36.15M(-179.3%) | -$7.08M(-235.6%) |
| Dec 2020 | -$2.11M(+97.7%) | $45.59M(+287.2%) | -$2.11M(+96.9%) |
| Sep 2020 | - | $11.78M(+141.6%) | -$68.06M(+32.7%) |
| Jun 2020 | - | -$28.30M(+9.2%) | -$101.11M(-3.7%) |
| Mar 2020 | - | -$31.18M(-53.1%) | -$97.54M(-4.3%) |
| Dec 2019 | -$93.53M(+8.4%) | -$20.36M(+4.3%) | -$93.53M(-9.1%) |
| Sep 2019 | - | -$21.27M(+14.0%) | -$85.70M(+11.7%) |
| Jun 2019 | - | -$24.73M(+9.0%) | -$97.02M(+2.2%) |
| Mar 2019 | - | -$27.16M(-116.7%) | -$99.20M(+2.8%) |
| Dec 2018 | -$102.10M(+2.4%) | -$12.54M(+61.5%) | -$102.10M(+10.8%) |
| Sep 2018 | - | -$32.59M(-21.1%) | -$114.42M(-6.2%) |
| Jun 2018 | - | -$26.91M(+10.5%) | -$107.76M(+4.1%) |
| Mar 2018 | - | -$30.07M(-21.0%) | -$112.37M(-7.4%) |
| Dec 2017 | -$104.64M(-395.7%) | -$24.85M(+4.2%) | -$104.64M(-3623.7%) |
| Sep 2017 | - | -$25.93M(+17.7%) | -$2.81M(-126.3%) |
| Jun 2017 | - | -$31.52M(-41.1%) | $10.70M(-65.5%) |
| Mar 2017 | - | -$22.33M(-129.0%) | $30.98M(-12.4%) |
| Dec 2016 | $35.39M(+718.9%) | $76.97M(+719.4%) | $35.39M(+168.4%) |
| Sep 2016 | - | -$12.43M(-10.6%) | -$51.73M(-4.1%) |
| Jun 2016 | - | -$11.23M(+37.3%) | -$49.71M(-3.9%) |
| Mar 2016 | - | -$17.93M(-76.7%) | -$47.84M(-1207.0%) |
| Dec 2015 | $4.32M(+109.4%) | -$10.15M(+2.4%) | $4.32M(-29.0%) |
| Sep 2015 | - | -$10.40M(-11.1%) | $6.09M(-11.4%) |
| Jun 2015 | - | -$9.36M(-127.4%) | $6.88M(+6.8%) |
| Mar 2015 | - | $34.23M(+508.6%) | $6.44M(+114.0%) |
| Dec 2014 | -$45.95M | -$8.38M(+12.9%) | -$45.95M(+8.6%) |
| Sep 2014 | - | -$9.62M(+1.9%) | -$50.25M(-65.3%) |
| Jun 2014 | - | -$9.80M(+46.0%) | -$30.40M(-116.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$18.16M(-43.2%) | -$14.02M(-69.7%) |
| Dec 2013 | -$8.26M(+75.4%) | -$12.68M(-223.8%) | -$8.26M(-199.1%) |
| Sep 2013 | - | $10.24M(+55.6%) | -$2.76M(+87.4%) |
| Jun 2013 | - | $6.58M(+153.1%) | -$21.93M(+41.1%) |
| Mar 2013 | - | -$12.40M(-72.6%) | -$37.21M(-10.9%) |
| Dec 2012 | -$33.56M(+27.1%) | -$7.18M(+19.5%) | -$33.56M(+10.1%) |
| Sep 2012 | - | -$8.92M(-2.5%) | -$37.35M(+1.2%) |
| Jun 2012 | - | -$8.71M(+0.5%) | -$37.79M(+9.4%) |
| Mar 2012 | - | -$8.75M(+20.2%) | -$41.73M(+9.4%) |
| Dec 2011 | -$46.04M(-1.6%) | -$10.97M(-17.1%) | -$46.04M(-4.1%) |
| Sep 2011 | - | -$9.37M(+26.0%) | -$44.25M(+2.4%) |
| Jun 2011 | - | -$12.65M(+3.1%) | -$45.33M(+1.5%) |
| Mar 2011 | - | -$13.05M(-42.2%) | -$46.02M(-1.5%) |
| Dec 2010 | -$45.32M(-676.2%) | -$9.18M(+12.2%) | -$45.32M(-6.1%) |
| Sep 2010 | - | -$10.45M(+21.6%) | -$42.70M(+2.7%) |
| Jun 2010 | - | -$13.33M(-7.9%) | -$43.89M(-684.3%) |
| Mar 2010 | - | -$12.36M(-88.5%) | $7.51M(-4.5%) |
| Dec 2009 | $7.87M(+112.7%) | -$6.56M(+43.7%) | $7.87M(+491.0%) |
| Sep 2009 | - | -$11.64M(-130.6%) | $1.33M(+136.2%) |
| Jun 2009 | - | $38.07M(+417.0%) | -$3.68M(+93.8%) |
| Mar 2009 | - | -$12.01M(+8.3%) | -$59.79M(+3.5%) |
| Dec 2008 | -$61.99M(-1013.3%) | -$13.09M(+21.4%) | -$61.99M(+2.1%) |
| Sep 2008 | - | -$16.65M(+7.7%) | -$63.33M(-10.8%) |
| Jun 2008 | - | -$18.04M(-27.1%) | -$57.15M(-8.1%) |
| Mar 2008 | - | -$14.20M(+1.6%) | -$52.84M(-849.0%) |
| Dec 2007 | -$5.57M(+89.4%) | -$14.43M(-37.9%) | -$5.57M(+6.3%) |
| Sep 2007 | - | -$10.47M(+23.8%) | -$5.94M(+33.8%) |
| Jun 2007 | - | -$13.74M(-141.5%) | -$8.97M(-18.8%) |
| Mar 2007 | - | $33.07M(+323.4%) | -$7.55M(+85.6%) |
| Dec 2006 | -$52.54M(-28.3%) | -$14.81M(-9.7%) | -$52.54M(-9.4%) |
| Sep 2006 | - | -$13.50M(-9.6%) | -$48.03M(-9.9%) |
| Jun 2006 | - | -$12.32M(-3.4%) | -$43.69M(+0.2%) |
| Mar 2006 | - | -$11.91M(-15.7%) | -$43.79M(-6.9%) |
| Dec 2005 | -$40.95M(-15.6%) | -$10.30M(-12.4%) | -$40.95M(+2.6%) |
| Sep 2005 | - | -$9.16M(+26.3%) | -$42.02M(+2.1%) |
| Jun 2005 | - | -$12.42M(-36.9%) | -$42.93M(-14.9%) |
| Mar 2005 | - | -$9.07M(+20.2%) | -$37.36M(-5.4%) |
| Dec 2004 | -$35.43M(-5.6%) | -$11.37M(-13.0%) | -$35.43M(-47.2%) |
| Sep 2004 | - | -$10.06M(-46.9%) | -$24.06M(-71.9%) |
| Jun 2004 | - | -$6.85M(+4.2%) | -$14.00M(-95.8%) |
| Mar 2004 | - | -$7.15M | -$7.15M |
| Dec 2003 | -$33.56M(-16.2%) | - | - |
| Dec 2002 | -$28.87M(-416.6%) | - | - |
| Dec 2001 | -$5.59M(+58.8%) | - | - |
| Dec 2000 | -$13.56M | - | - |
FAQ
- What is Cytokinetics, Incorporated annual free cash flow?
- What is the all-time high annual free cash flow for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual free cash flow year-on-year change?
- What is Cytokinetics, Incorporated quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly free cash flow year-on-year change?
- What is Cytokinetics, Incorporated TTM free cash flow?
- What is the all-time high TTM free cash flow for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM free cash flow year-on-year change?
What is Cytokinetics, Incorporated annual free cash flow?
The current annual free cash flow of CYTK is -$399.80M
What is the all-time high annual free cash flow for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual free cash flow is $35.39M
What is Cytokinetics, Incorporated annual free cash flow year-on-year change?
Over the past year, CYTK annual free cash flow has changed by +$15.95M (+3.84%)
What is Cytokinetics, Incorporated quarterly free cash flow?
The current quarterly free cash flow of CYTK is -$132.38M
What is the all-time high quarterly free cash flow for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly free cash flow is $76.97M
What is Cytokinetics, Incorporated quarterly free cash flow year-on-year change?
Over the past year, CYTK quarterly free cash flow has changed by -$31.15M (-30.78%)
What is Cytokinetics, Incorporated TTM free cash flow?
The current TTM free cash flow of CYTK is -$438.72M
What is the all-time high TTM free cash flow for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM free cash flow is $35.39M
What is Cytokinetics, Incorporated TTM free cash flow year-on-year change?
Over the past year, CYTK TTM free cash flow has changed by -$37.45M (-9.33%)